Condition

Pancreatic Cancer (2)

Anaplastic Astrocytoma (1)

Anaplastic Oligodendroglioma (1)

Colorectal Cancer (1)

Gastrointestinal Carcinoid Tumor (1)

Glioblastoma Multiforme (1)

Islet Cell Tumor (1)

Mixed Gliomas (1)

Recurrent Brain Tumor (1)

Overall Status

Completed (3)

Recruiting (1)

Terminated (1)

Phase

phase 2 (4)

phase 1 (1)

Sponsor

Cambridge University Hospitals NHS Foundation Trust (1)

Emory University (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

H. Lee Moffitt Cancer Center and Research Institute (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Genentech, Inc. (1)

National Cancer Institute (NCI) (1)

National Cancer Institute, France (1)

Study Documents

Intervention Type

drug (5)

biological (1)

genetic (1)

other (1)

Funder Type

Other (5)

Study Type

Interventional (5)

streptozocin

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreatic Cancer Trial in Villejuif (LV5FU2, Streptozocin, Capecitabine)

Recruiting

Pancreatic Cancer

LV5FU2
+4 more

Villejuif, Val De Marne, France

Gustave Roussy

Jan 6, 2020

Pancreatic Cancer Trial in Tampa (Avastin, Fluorouracil, Doxorubicin)

Terminated

Has Results

Pancreatic Cancer

Avastin
+5 more

Tampa, Florida

H. Lee Moffitt Cancer Center and Research Institute

Feb 20, 2017

Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas Trial (carmustine, mercaptopurine, streptozocin)

Completed

Anaplastic Astrocytoma
+4 more

carmustine
+2 more

(no location specified)

Mar 24, 2015

Gastrointestinal Carcinoid Tumor, Islet Cell Tumor Trial in United Kingdom (drug, genetic, other)

Completed

Gastrointestinal Carcinoid Tumor
Islet Cell Tumor

capecitabine
+7 more

Basildon, England, United Kingdom
+16 more

Aug 6, 2013

Colorectal Cancer Trial in New York (mAb A33, carmustine, fluorouracil)

Completed

Colorectal Cancer

monoclonal antibody A33
+4 more

New York, New York

Memorial Sloan-Kettering Cancer Center

Jun 25, 2013